Avidity Biosciences
RNAM
#1865
Rank
NZ$19.17 B
Marketcap
NZ$124.15
Share price
0.00%
Change (1 day)
117.85%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Market cap: NZ$19.17 Billion

As of July 2026 Avidity Biosciences has a market cap of NZ$19.17 Billion. This makes Avidity Biosciences the world's 1865th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026NZ$19.17 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$240.49 B 1,153.97%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$170.86 B 790.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$3.02 B-84.20%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
NZ$11.03 B-42.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.55 B-97.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$1.39 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
NZ$18.63 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$6.57 B-65.73%๐Ÿ‡บ๐Ÿ‡ธ USA